Nuvation Bio

Quarterly Financials

Values in thousands 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue
$4,833
$3,084
$5,711
$727
Gross Profit
2,257
990
1,495
-788
EBITDA
-58,586
-59,004
-49,137
-41,090
EBIT
-59,314
-49,356
-41,252
Net Income
-59,007
-53,236
-49,445
-41,210
Net Change In Cash
4,833
3,084
5,711
727
Free Cash Flow
-48,359
-42,699
-46,289
-31,233
Cash
247,970
47,977
35,723
30,036
Basic Shares
340,746
338,612
336,934
273,565

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$7,873
$0
$0
$0
Gross Profit
795
-222
-484
-368
EBITDA
-566,915
-99,600
-119,535
-89,347
EBIT
-567,598
-99,822
-120,019
-89,715
Net Income
-567,939
-75,802
-104,199
-86,848
Net Change In Cash
7,873
0
0
0
Cost of Revenue
-31,324
102,668
Free Cash Flow
-130,575
-68,068
-96,478
-68,472
Cash
35,723
42,649
101,099
132,423
Basic Shares
268,772
218,880
216,721
197,887

Earnings Calls

Quarter EPS
2025-09-30
$0
2025-06-30
-$0.17
2025-03-31
-$0.13
2024-12-31
-$0.11